Roche Holding AG (Roche Holding AG) 3-Year EBITDA Growth Rate : -4.70% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Roche Holding AG 3-Year EBITDA Growth Rate?

Roche Holding AG's EBITDA per Share for the six months ended in Dec. 2023 was $1.28.

During the past 12 months, Roche Holding AG's average EBITDA Per Share Growth Rate was -10.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -4.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Roche Holding AG was 57.70% per year. The lowest was -34.40% per year. And the median was 0.90% per year.

Competitive Comparison of Roche Holding AG's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Roche Holding AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's 3-Year EBITDA Growth Rate falls into.

Roche Holding AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Roche Holding AG (OTCPK:RHHBY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Roche Holding AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.